Screening for high blood pressure: Recommendations and rationale

American Journal of Preventive Medicine

Volumn 25, Issue 2, 2003, Pages 159-164

  Berg, Alfred O ^a  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DRUG EFFICACY; HUMAN; HYPERTENSION; MASS SCREENING; MEDICAL PRACTICE; MENTAL DISEASE; REVIEW; SIDE EFFECT; UNITED STATES;

EID: 0041667944     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(03)00122-3     Document Type: Article

References (46)

1. Guide to Clinical Preventive Services, 2nd ed. 1996;International Medical Publishing, Inc, Alexandria VA.
2. Sheridan S, Pignone M, Donahue K. Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force. Am J Prev Med 2003;25:151-8.
3. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
4. Padwal R., Straus S.E., McAlister F.A. Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension evidence based review . BMJ. 322:2001;977-980.
5. Klein R., Klein B.E., Moss S.E. The relation of systemic hypertension to changes in the retinal vasculature the Beaver Dam Eye Study . Trans Am Ophthalmol Soc. 95:1997;329-348. discussion 348-50.
6. Lederle F.A., Johnson G.R., Wilson S.E., et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med. 126:1997;441-449.
7. Hodgson T.A., Cai L. Medical care expenditures for hypertension, its complications, and its comorbidities. Med Care. 39:2001;599-615.
8. Collins R., Peto R., MacMahon S., et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure overview of randomised drug trials in their epidemiological context . Lancet. 335:1990;827-838.
9. Adrogue H.E., Sinaiko A.R. Prevalence of hypertension in junior high school-aged children effect of new recommendations in the 1996 Updated Task Force Report . Am J Hypertens. 14:(5 Pt 1):2001;412-414.
10. Bradley C.B., Harrell J.S., McMurray R.G., Bangdiwala S.I., Frauman A.C., Webb J.P. Prevalence of high cholesterol, high blood pressure, and smoking among elementary schoolchildren in North Carolina. N C Med J. 58:1997;362-367.
11. Feld L.G., Springate J.E. Hypertension in children. Curr Probl Pediatrics. 18:1988;317-373.
12. Reeves R.A. Does this patient have hypertension? How to measure blood pressure. JAMA. 273:1995;1211-1218.
13. McAlister F.A., Straus S.E. Evidence based treatment of hypertension. Measurement of blood pressure an evidence based review . BMJ. 322:2001;908-911.
14. Myers M.G., Haynes R.B., Rabkin S.W. Canadian hypertension society guidelines for ambulatory blood pressure monitoring. Am J Hypertens. 12:(11 Pt 1):1999;1149-1157.
15. Verdecchia P., Porcellati C., Schillaci G., et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 24:1994;793-801.
16. Khattar R.S., Swales J.D., Banfield A., Dore C., Senior R., Lahiri A. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation. 100:1999;1071-1076.
17. Staessen J.A., Thijs L., Fagard R., et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 282:1999;539-546.
18. Appel LJ, Robinson KA, Guallar EG, et al. Utility of Blood Pressure Monitoring Outside of the Clinic Setting. Evidence Report/Technology Assessment Number 63. AHRQ Publication No. 03-E004. Rockville MD: Agency for Healthcare Research and Quality, November 2002. Also available at: http://www.ahrq.gov/clinic/bpmoninv.htm.
19. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) . JAMA. 283:2000;1967-1975.
20. Major outcomes in high-risk hypertensive patients randomized to Angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) . JAMA. 288:2002;2981-2997.
21. Gueyffier F., Froment A., Gouton M. New meta-analysis of treatment trials of hypertension improving the estimate of therapeutic benefit . J Hum Hypertens. 10:1996;1-8.
22. Staessen J.A., Gasowski J., Wang J.G., et al. Risks of untreated and treated isolated systolic hypertension in the elderly meta-analysis of outcome trials . Lancet. 355:2000;865-872.
23. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13.
24. Hansson L., Zanchetti A., Carruthers S.G., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group . Lancet. 351:1998;1755-1762.
25. Leiter L.A., Abbott D., Campbell N.R., Mendelson R., Ogilvie R.I., Chockalingam A. Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ. 160:(suppl 9):1999;S7-S12.
26. Cleroux J., Feldman R.D., Petrella R.J. Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ. 160:(suppl 9):1999;S21-S28.
27. Cutler J.A., Follmann D., Allender P.S. Randomized trials of sodium reduction an overview . Am J Clin Nutr. 65:(suppl 2):1997;643S-651S.
28. Midgley J.P., Matthew A.G., Greenwood C.M., Logan A.G. Effect of reduced dietary sodium on blood pressure a meta-analysis of randomized controlled trials . JAMA. 275:1996;1590-1597.
29. Whelton P.K., He J., Cutler J.A., et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 277:1997;1624-1632.
30. Xin X., He J., Frontini M.G., Ogden L.G., Motsamai O.I., Whelton P.K. Effects of alcohol reduction on blood pressure a meta-analysis of randomized controlled trials . Hypertension. 38:2001;1112-1117.
31. Ameling E.H., de Korte D.F., Man in 't Veld A. Impact of diagnosis and treatment of hypertension on quality of life a double-blind, randomized, placebo-controlled, cross-over study of betaxolol . J Cardiovasc Pharmacol. 18:1991;752-760.
32. Mann A.H. The psychological effect of a screening programme and clinical trial for hypertension upon the participants. Psychol Med. 7:1977;431-438.
33. Ambrosio G.B., Dissegna L., Zamboni S., Santonastaso P., Canton G., Dal Palu C. Psychological effects of hypertension labelling during a community survey. A two-year follow-up. J Hypertens Suppl. 2:1984;S171-S173.
34. Rudd P., Price M.G., Graham L.E., et al. Consequences of worksite hypertension screening. Differential changes in psychosocial function. Am J Med. 80:1986;853-860.
35. Rudd P., Price M.G., Graham L.E., et al. Consequences of worksite hypertension screening. Changes in absenteeism. Hypertension. 10:1987;425-436.
36. Rastam L., Ryden L. Work absenteeism and well-being in patients treated for hypertension. Eur Heart J. 8:1987;1024-1031.
37. Alderman M.H., Davis T.K. Hypertension control at the work site. J Occup Med. 18:1976;793-796.
38. Pearson T.A., Blair S.N., Daniels S.R., et al. AHA guidelines for primary prevention of cardiovascular disease and stroke 2002 Update . Circulation. 106:2002;388-391.
39. American Academy of Family Physicians (AAFP). Age charts for periodic health examinations. Revision 5.1 ed. Vol. 2002; 2001.
40. American College of Obstetricians and Gynecologists (ACOG). Guidelines for Women's Health care, 2nd ed. Washington DC: ACOG; 2002:121-34.
41. Recommendations for preventive pediatric health care. Committee on Practice and Ambulatory Medicine. Pediatrics 1995;96(2 Pt 1):373-4.
42. Report of the Second Task Force on Blood Pressure Control in Children - 1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987;79:1-25.
43. American Heart Association (AHA). High blood pressure in children. Vol. 2002; 2002.
44. Bright Futures: guidelines for health supervision of infants, children, and adolescents. Arlington VA: National Center for Education in Maternal and Child Health, 2002.
45. American Medical Association. Guidelines for Adolescent Preventive Services (GAPS). Vol. 2002; 1997.
46. Routine evaluation of blood pressure, hematocrit, and glucose in newborns. Pediatrics. 92:1993;474-476.